Bearberry Leaf
Uvae ursi folium
Arctostaphylos uva-ursi (L.) Spreng.
HOS-216041hmpc:uvae-ursi-folium
Botanische Abbildung
Kinnikinnick
Artbezogene Illustration. Sie zeigt nicht automatisch die im Profil genannte Arzneidroge oder Zubereitung und dient nicht zur sicheren Bestimmung einer Giftpflanze.
Walter Siegmund · CC BY 2.5 · Bildquelle ↗
Bildzuordnung & Herkunft
- Originalangabe im Profil
- Arctostaphylos uva-ursi (L.) Spreng.
- Taxonkennung
- Q208032 · Quellenrevision 2538295136
- Bearbeitung
- Auf maximal 1024 Pixel verkleinert, EXIF-Orientierung angewandt und als JPEG gespeichert; kein inhaltlicher Zuschnitt.
- Bildquelle abgerufen
- 25.10.2026
Bilddatei SHA-256: 7a78d93a5405330ad0c1738347f81d49887a9edfa939d5aab5a4a607d389ba29
- Themengebiete laut EMA
- Urinary tract and genital disorders
- Ergebnis der Bewertung laut EMA
- European Union herbal monograph
- Kombination laut EMA
- Nein
Pflanzen–Arzneimittel-Beziehungen 0 belegte Zuordnungen
Für diesen Quellenstand wurden noch keine eindeutigen Wirkstoffzuordnungen mit belegter Aussage übernommen.
Keine oder wenige Zuordnungen bedeuten nicht, dass keine Wechselwirkungen bestehen. Nicht eindeutig zuordenbare Aussagen bleiben im Originalabschnitt nachlesbar; verneinte Befunde gelten nur für die beschriebenen Bedingungen.
Sicherheit aus der Monographie Originalabschnitte
Englische Originalabschnitte mit unveränderten Spalten für etablierte und traditionelle Anwendung. Aussagen gelten für die im Dokument genannten Zubereitungen und Anwendungsarten. Aus ihnen werden hier keine Interaktionspaare oder Schweregrade abgeleitet.
Final European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium - Revision 2 ↗
PDF abgerufen: 27.10.2026 · 7 Seiten · automatisch ausgelesen
Zubereitungs- und Anwendungskontext · Originaltext
Originalkontext vor Abschnitt 4.3, einschließlich der Angaben zu Zubereitungen und Anwendung. Buchstaben und Nummern der Zubereitungen werden in den Sicherheitsabschnitten wieder aufgegriffen.
1. Name of the medicinal product
To be specified for the individual finished product.
2. Qualitative and quantitative composition 1, 2
Well-established use Traditional use
With regard to the registration application of Article
16d(1) of Directive 2001/83/EC
Arctostaphylos uva-ursi (L.) Spreng., folium
(bearberry leaf)
i) Herbal substance
Not applicable
ii) Herbal preparations
a) Comminuted herbal substance
b) Powdered herbal substance
c) Dry extract (DER 3.5-5.5:1), extraction solvent
ethanol 60% V/V, containing
23.5-29.3% of hydroquinone derivatives
calculated as anhydrous arbutin
(spectrophotometry)
d) Dry extract (DER 2.5-4.5:1), extraction solvent
water, containing 20-28% of hydroquinone
derivatives calculated as anhydrous arbutin
(spectrophotometry)
e) Liquid extract (DER 1:1), extraction
solvent ethanol 25% V/V
3. Pharmaceutical form
Well-established use Traditional use
Comminuted herbal substance as herbal tea for oral
use.
Herbal preparations in liquid or solid dosage forms for
1
The declaration of the active substance(s) for an individual finished product should be in accordance with relevant herbal
quality guidance.
2
The material complies with the Ph. Eur. monograph (ref.: 1054)
European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium
EMA/HMPC/750269/2016 Page 3/7
Well-established use Traditional use
oral use.
The pharmaceutical form should be described by the
European Pharmacopoeia full standard term.
4. Clinical particulars
4.1. Therapeutic indications
Well-established use Traditional use
Traditional herbal medicinal product used for relief of
symptoms of mild recurrent lower urinary tract
infections such as burning sensation during urination
and/or frequent urination in women, after serious
conditions have been excluded by a medical doctor.
The product is a traditional herbal medicinal product
for use in the specified indication exclusively based
upon long-standing use.
4.2. Posology and method of administration 3
Well-established use Traditional use
Posology
Female adults and elderly
a) Comminuted herbal substance
Herbal tea: 1.5-4 g of the comminuted herbal
substance in 150 ml of boiling water as a herbal
infusion or in 150 ml of water as a macerate 2 to 4
times daily
Maximum daily dose: 8 g
b) Powdered herbal substance
Single dose: 700 – 1050 mg twice daily
Maximum daily dose: 1.75 g
c) and d) Dry extracts
Single dose: the dose corresponding to 100–210 mg
of hydroquinone derivatives calculated as anhydrous
arbutin 2–4 times daily
Daily dose: the dose corresponding to 200–840 mg of
hydroquinone derivatives calculated as anhydrous
3
For guidance on herbal substance/herbal preparation administered as herbal tea or as infusion/decoction/macerate
preparation, please refer to the HMPC ‘Glossary on herbal teas’ (EMA/HMPC/5829/2010 Rev.1).
European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium
EMA/HMPC/750269/2016 Page 4/7
Well-established use Traditional use
arbutin
e) Liquid extract
Single dose: 1.5–4 ml up to three times daily
Maximum daily dose: 8 ml
The use in children and adolescents under 18 years of
age is not recommended (see section 4.4 ‘Special
warnings and precautions for use’).
The use in men is not recommended (see section 4.4
‘Special warnings and precautions for use’).
Duration of use
Not to be used for more than one week.
If the symptoms persist for more than 4 days during
the use of the medicinal product, a doctor or a
qualified health care practitioner should be consulted.
Method of administration
Oral use
The macerate should be used immediately after
preparation.Kontext im Original-PDF öffnen ↗4.3 · Gegenanzeigen
Contraindications
4.3. Contraindications
Well-established use Traditional use
Hypersensitivity to the active substance.
Kidney disordersOriginal-PDF · Seite 5 ↗4.4 · Warnhinweise und Vorsichtsmaßnahmen
Special warnings and precautions for use
4.4. Special warnings and precautions for use
Well-established use Traditional use
The use in children and adolescents under 18 years of
age is not recommended because of concerns
requiring medical advice.
The use in men is not recommended because of
concerns requiring medical supervision.
If the symptoms worsen or if complaints such as
fever, dysuria, spasms, or blood in urine occur during
the use of the medicinal product, a doctor or a
qualified health care practitioner should be consulted.
Uvae ursi folium may cause a greenish-brown
coloration of the urine.
European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium
EMA/HMPC/750269/2016 Page 5/7
Well-established use Traditional use
For extracts containing ethanol, the appropriate
labelling for ethanol, taken from the ‘Guideline on
excipients in the label and package leaflet of
medicinal products for human use’, must be included.Original-PDF · Seite 5–6 ↗4.5 · Wechselwirkungen
Interactions with other medicinal products and other forms of interaction
4.5. Interactions with other medicinal products and other forms of
interaction
Well-established use Traditional use
None reportedOriginal-PDF · Seite 6 ↗4.8 · Nebenwirkungen
Undesirable effects
4.8. Undesirable effects
Well-established use Traditional use
Nausea, vomiting, stomach-ache have been reported.
The frequency is not known.
If other adverse reactions not mentioned above
occur, a doctor or a qualified health care practitioner
should be consulted.Original-PDF · Seite 6 ↗Dokumentfassung nachweisen
SHA-256: b3675ab61c5771f570a13e7c9aa563b2762964c110c38f955c730e853bcf261e
Der Hash kennzeichnet die abgerufene Datei. Die Dokumentfassung und der Bearbeitungsstatus des Pflanzenprofils sind getrennte Angaben.
Importstand: 27.10.2026 · Aktuelles EMA-Quellenprofil ↗
Dokumente beim Herausgeber · 18
Originaltitel bleiben erhalten. Entwürfe, ältere Fassungen und ergänzende Berichte können nebeneinander vorliegen; der Profilstatus bestimmt nicht die Gültigkeit jedes Dokuments.
- Call for scientific data for the periodic review of the monograph on Uvae ursi folium
- Call for scientific data for the systematic review of the monograph on Arctostaphylos uva-ursi (L.) Spreng., folium
- Call for submission of scientific data relating to the assessment of Uvae ursi folium Arctostaphylos uva-ursi (L.) Spreng., folium
- Final overview of comments received on European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium (EMA/HMPC/750269/2016) - Revision 2
- Superseded overview of comments received on Community herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium - Revision 1
- Draft European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium
- Final European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium - Revision 2
- Superseded Community herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium - Revision 1
- Opinion of the HMPC on a European Union herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium - Revision 2
- Superseded opinion of the HMPC on a community herbal monograph on Arctostaphylos uva-ursi (L.) Spreng., folium - Revision 1
- Draft list of references supporting the assessment of Arctostaphylos uva-ursi (L.) Spreng., folium
- Final list of references supporting the assessment of Arctostaphylos uva-ursi (L.) Spreng., folium - Revision 2
- Superseded list of references supporting the assessment of Arctostaphylos uva-ursi (L.) Spreng., folium - Revision 1
- Addendum to Assessment report on Arctostaphylos uva-ursi (L.) Spreng., folium
- Draft assessment report on Arctostaphylos uva-ursi (L.) Spreng., folium
- Final assessment report on Arctostaphylos uva-ursi (L.) Spreng., folium - Revision 2
- Superseded assessment report on Arctostaphylos uva-ursi (L.) Spreng., folium - Revision 1
- Bearberry leaf: Summary for the public
Dokumentenlinks geprüft: 27.10.2026
Quellenstand & Originalangaben
- Originalstatus
- C: ongoing call for scientific data
- Zuletzt geändert laut EMA
- 30/04/2025
- Erstveröffentlichung laut EMA
- 31/12/2009
- Erfolgreicher Quellenabruf
- 27.10.2026